Rothschild Investment LLC Purchases 6,380 Shares of Danaher Corporation $DHR

Rothschild Investment LLC grew its position in Danaher Corporation (NYSE:DHR) by 119.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,728 shares of the conglomerate’s stock after acquiring an additional 6,380 shares during the quarter. Rothschild Investment LLC’s holdings in Danaher were worth $2,325,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new position in shares of Danaher in the second quarter valued at $1,979,503,000. Viking Global Investors LP increased its holdings in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after buying an additional 2,455,994 shares during the period. Generation Investment Management LLP raised its stake in shares of Danaher by 56.2% in the 2nd quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock valued at $980,914,000 after buying an additional 1,787,522 shares in the last quarter. Primecap Management Co. CA lifted its holdings in shares of Danaher by 924.2% during the 2nd quarter. Primecap Management Co. CA now owns 1,239,320 shares of the conglomerate’s stock worth $244,815,000 after acquiring an additional 1,118,318 shares during the period. Finally, Vanguard Group Inc. increased its stake in Danaher by 1.3% in the second quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock valued at $12,004,424,000 after acquiring an additional 788,499 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 0.3%

DHR stock opened at $234.92 on Friday. The business has a fifty day moving average price of $225.31 and a 200 day moving average price of $210.22. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The stock has a market capitalization of $165.94 billion, a price-to-earnings ratio of 48.44, a P/E/G ratio of 4.19 and a beta of 0.89.

Danaher (NYSE:DHR) last announced its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the prior year, the business earned $1.71 earnings per share. The business’s revenue for the quarter was up 4.4% on a year-over-year basis. Analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Insiders Place Their Bets

In related news, SVP Georgeann Couchara sold 5,174 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares in the company, valued at $552,352.50. The trade was a 66.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 30,248 shares of company stock valued at $6,609,663. Insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. TD Cowen increased their target price on Danaher from $260.00 to $270.00 and gave the stock a “buy” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft boosted their price target on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. The Goldman Sachs Group assumed coverage on Danaher in a research report on Tuesday, December 9th. They issued a “buy” rating and a $265.00 price target on the stock. Finally, HSBC lifted their price objective on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Monday, December 1st. Twenty-one research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $249.92.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.